Uncategorized
Topical NSAID prevents pseudophakic CME in eyes with certain risk factors
CHICAGO — The use of once-daily 0.3% nepafenac after cataract surgery can help prevent pseudophakic cystoid macular edema in eyes with certain risk factors, but did not improve PCME outcomes in eyes without those risk factors, according to a presenter here. “We are able to show we had a significantly improved PCME outcome with risk factors. This is, in the general ophthalmology practice, about 10% to 30% of patients. However, in 70% to 90% of the patients, it is unlikely that clinical PCME outcomes are improved in those patients without (Read more...)